Electronic Cigarettes clinical trials at UCSF
2 research studies open to eligible people
Electronic cigarettes are devices that produce vapor that users inhale. UCSF is currently conducting clinical trials to study the short-term cardiovascular effects of different e-liquid pH levels and the use behaviors, chemical exposures, and biological effects of a standardized research electronic cigarette. These studies will help us better understand the health impacts of e-cigarette use.
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
open to eligible people ages 21-70
This is a crossover study that will examine use behaviors, chemical exposures, and biological effects of Standardized Research Electronic Cigarette (SREC) compared to usual brand e-cigarette use in natural or synthetic nicotine users.
San Francisco, California
Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH
open to eligible people ages 21-70
This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.
San Francisco, California and other locations
Our lead scientists for Electronic Cigarettes research studies include Gideon St.Helen Neal Benowitz, MD.
Last updated: